Lataa...
Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
BACKGROUND: Dabigatran and rivaroxaban are new oral anticoagulants that are eliminated through the kidneys. Their use in dialysis patients is discouraged because these drugs can bio-accumulate to precipitate inadvertent bleeding. We wanted to determine if prescription of dabigatran or rivaroxaban wa...
Tallennettuna:
| Julkaisussa: | Circulation |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363265/ https://ncbi.nlm.nih.gov/pubmed/25595139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.014113 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|